A proposal for risk-based and strategy-adapted de-escalation in human papillomavirus-positive oropharyngeal squamous cell carcinoma

Cancer. 2021 Dec 1;127(23):4330-4338. doi: 10.1002/cncr.33851. Epub 2021 Aug 11.

Authors

Michael T Wotman¹, Brett A Miles², Richard L Bakst³, Marshall R Posner⁴

Affiliations

¹ The Department of Internal Medicine in the Icahn School of Medicine at Mount Sinai, New York, New York.
² The Department of Otolaryngology in the Icahn School of Medicine at Mount Sinai, New York, New York.
³ The Department of Radiation Oncology in the Icahn School of Medicine at Mount Sinai, New York, New York.
⁴ The Department of Hematology/Oncology in the Icahn School of Medicine at Mount Sinai, New York, New York.

PMID: 34379804
DOI: 10.1002/cncr.33851

No abstract available

Keywords: chemotherapy; de-escalation; human papillomavirus; oropharyngeal neoplasms; radiotherapy.

MeSH terms

Alphapapillomavirus*
Head and Neck Neoplasms*
Humans
Oropharyngeal Neoplasms*
Papillomaviridae
Papillomavirus Infections* / complications
Squamous Cell Carcinoma of Head and Neck